News 
Market Data 
Discover
EagleD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AGNPF | Algernon Pharmaceuticals Inc | 0.0778 | -0.00454 | -5.51% | 04/23/2020 | |||||
|
My AGNPF Pitch: $AGNPF Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
The 40-patient, 4-week trial, is designed to test the effect of Ifenprodil in COVID-19 infected patients with severe pneumonia. Enrollment is expected to begin 5/8/20 |
||||||||||
| DTSL | Delivery Technology Solutions, Inc. | 0.000001 | 0.0 | 0.00% | 02/13/2011 | |||||
|
My DTSL Pitch: DTSL, ready to go big!
|
||||||||||
